Loading…
Use of an NK1 Receptor Antagonist to Prevent Delayed Emesis After Cisplatin
Kris et al evaluated the NK1 receptor antagonist CP-122,721 in 17 cancer patients receiving cisplatin that induces acute vomiting in 98% of the patients not receiving antiemetics and delayed vomiting in 89%.
Saved in:
Published in: | JNCI : Journal of the National Cancer Institute 1997-06, Vol.89 (11), p.817-818 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Kris et al evaluated the NK1 receptor antagonist CP-122,721 in 17 cancer patients receiving cisplatin that induces acute vomiting in 98% of the patients not receiving antiemetics and delayed vomiting in 89%. |
---|---|
ISSN: | 0027-8874 1460-2105 |
DOI: | 10.1093/jnci/89.11.817 |